{"schema_version":"secwatch.filing_event.v1","accession":"0000010795-24-000036","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.197907+00:00","generated_at":"2026-06-02T23:52:26.490591+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BD Q2 revenue $5.0B (+4.6%), adj. EPS $3.17 (+10.8%); raises FY24 adjusted EPS guidance","bullets":["Q2 revenue $5,045M (+4.6% reported, +5.7% organic); GAAP diluted EPS $1.85 (+20.9%), adjusted EPS $3.17 (+10.8%).","Year-to-date Cash from Ops $1.4B; Free Cash Flow $1.1B, up >$900M YoY.","Company raises full-year adjusted EPS guidance and affirms organic revenue growth forecast.","BD Medical increasing domestic syringe production after FDA safety communication on non-BD syringes.","BD Life Sciences launched three- and four-laser additions to BD FACSDiscover S8 Cell Sorter family."],"urls":{"canonical":"https://secwatch.observer/filing/0000010795-24-000036","json":"https://secwatch.observer/filing/0000010795-24-000036.json","markdown":"https://secwatch.observer/filing/0000010795-24-000036.md","text":"https://secwatch.observer/filing/0000010795-24-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000036/0000010795-24-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000036/bdx-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:52:26.490591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe14d6b2bd8dd1185075d506df7ab6737f20ae46","claim":"BECTON DICKINSON & CO updated its its second quarter of fiscal 2024, which ended March 31, 2024 guidance (raised).","evidence_excerpt":"On May 2, 2024, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its second fiscal quarter ending March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000036/0000010795-24-000036-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"its second quarter of fiscal 2024, which ended March 31, 2024"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}